Affimed Therapeutics, a German immuno-oncology biotech backed by several venture capital firms, has raised $43m in an IPO on the Nasdaq.
Also participating in the round were angel investors including the founders of Just Spices
Stake owned by EQT is transferred from EQT VII to its successor funds EQT VIII and EQT IX
Miya is a portfolio company of Bridgepoint Europe VI, a €5.7bn fund that invests in companies with EV of €200m-1bn
Mid-cap buyout-focused fund-of-funds closed on €162m and has made 14 of its 20 planned investments